1. Home
  2. USBC vs TOI Comparison

USBC vs TOI Comparison

Compare USBC & TOI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo USBC Inc.

USBC

USBC Inc.

N/A

Current Price

$0.69

Market Cap

333.2M

Sector

N/A

ML Signal

N/A

Logo The Oncology Institute Inc.

TOI

The Oncology Institute Inc.

HOLD

Current Price

$3.66

Market Cap

346.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
USBC
TOI
Founded
N/A
2007
Country
United States
Employees
6
N/A
Industry
Medical/Nursing Services
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
333.2M
346.3M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
USBC
TOI
Price
$0.69
$3.66
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$6.00
AVG Volume (30 Days)
N/A
1.6M
Earning Date
N/A
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$461,039,000.00
Revenue This Year
N/A
$28.51
Revenue Next Year
N/A
$23.54
P/E Ratio
N/A
N/A
Revenue Growth
N/A
21.67
52 Week Low
N/A
$0.21
52 Week High
N/A
$4.88

Technical Indicators

Market Signals
Indicator
USBC
TOI
Relative Strength Index (RSI) 40.94 54.74
Support Level $0.68 $3.23
Resistance Level $0.74 $3.90
Average True Range (ATR) 0.06 0.23
MACD -0.00 0.03
Stochastic Oscillator 10.04 65.10

Price Performance

Historical Comparison
USBC
TOI

About USBC USBC Inc.

USBC Inc is a non-invasive medical diagnostics. The group is focused on the development and commercialization of proprietary sensor technology utilizing radio and microwave dielectric spectroscopy. Its Sensor technology elicits a dielectric response that is different for every molecule. The group considers the business to currently have one operating segment: the development of its radio frequency spectroscopy technology, with a first focus on non-invasively ascertaining blood glucose levels.

About TOI The Oncology Institute Inc.

The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financial counseling, clinical trials, comprehensive lab testing, and end-of-life counseling. The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services. Majority of revenue is from patients services.

Share on Social Networks: